Pfizer (PFE)

$28.05 0.35 (1.26%)

19:00 EDT PFE Stock Quote Delayed 30 Minutes

7 Dividend Stocks to Buy for Income and Upside

By Alex Sirois, InvestorPlace Contributor Aug 9, 2023

These seven dividend stocks to buy provide the timeless combination of income and price appreciation potential for investors.

3 Massively Undervalued Blue-Chip Stocks for High Total Returns

3 Cheap Long-Term Stocks That Smart Investors Will Snap Up Now

Get Out Now! 7 Stocks to Dump After Sorry Q2 Earnings

Volume:

Previous Close -

Market Cap 157.27B

PE Ratio -561.00

EPS -0.05

Volume (Avg. Vol.) 17.27M

Day's Range $27.67 - $28.09

52-Week Range $25.20 - $37.80

Dividend & Yield $1.64 (5.85%)

PFE Stock Predictions, Articles, and Pfizer News

Looking for a Bargain? 7 Blue-Chip Stocks to Buy That Are Down 5% in 2023

By Muslim Farooque, InvestorPlace Contributor Aug 1, 2023

These discounted blue-chip stocks boast robust underlying businesses which present amazing long-term upside potential ahead

7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick

By Louis Navellier and the InvestorPlace Research Staff Jul 31, 2023

For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.

If You Can Only Buy 1 Blue-Chip Stock, It Better Be One of These Names

By Marie Brodbeck, InvestorPlace Contributor Jul 31, 2023

These three essential blue-chip stock picks come with solid business models, a good reputation, and strong financials.

3 Pharma Stocks to Buy for Their Promising Progress

By Muslim Farooque, InvestorPlace Contributor Jul 31, 2023

Explore the top promising pharma stocks, leading the proverbial marathon towards transformative healthcare .

3 Blue-Chip Stocks Trading at a Valuation Gap

By Faisal Humayun, InvestorPlace Contributor Jul 20, 2023

These are the undervalued blue-chip stocks to buy for high total returns in the next two years

3 Cheap Retirement Stocks for Your July Must-Buy List

By Charles Munyi, InvestorPlace Contributor Jul 16, 2023

These high-yielding cheap retirement stocks are in the bargain bin, yet they will grow earnings and increase their dividends going forward.

7 Undervalued Blue-Chip Stocks for High Total Returns

By Faisal Humayun, InvestorPlace Contributor Jul 15, 2023

These are the undervalued blue-chip stocks to buy at undervalued levels and represent companies with robust fundamentals.

3 Pharma Stocks That AI is Loving in July

By Chris Markoch, InvestorPlace Contributor Jul 13, 2023

Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.

The 7 Most Reliable Dividend Stocks to Buy for July 2023

By Josh Enomoto, InvestorPlace Contributor Jul 10, 2023

With much market uncertainty lying ahead, investors may want to consider these reliable dividend stocks to buy for (relative) security.

7 Blue-Chip Stocks to Sell Before They Do Your Portfolio In

By Chris Markoch, InvestorPlace Contributor Jul 9, 2023

The beginning of a new month, and a new earnings season gets investors thinking about which stocks to buy. They'll also be thinking about which…

The 7 Best Value Stocks to Buy in July

By Alex Sirois, InvestorPlace Contributor Jul 9, 2023

High potential value stocks offer investors growth and relative stability that many stocks simply cannot right now.

3 Cheap Stocks to Buy Before They Bounce Back

By Ian Bezek, InvestorPlace Contributor Jul 4, 2023

Afraid of missing out on the big market rally? These three cheap stocks are still strong buys today.

The 7 Most Undervalued S&P 500 Stocks to Buy Now

By Alex Sirois, InvestorPlace Contributor Jul 2, 2023

Undervalued S&P 500 stocks offer the stability of a well-established share at discount prices investors appreciate.

7 Safe Dividend Stocks for Investors to Buy Right Now: June 2023

By Josh Enomoto, InvestorPlace Contributor Jun 29, 2023

With investors possibly heading toward uncertain waters, they may find some confidence in these safe dividend stocks to buy.

3 Pharma Stocks That Have Big Investors Running for the Exit

By Joel Baglole, InvestorPlace Contributor Jun 28, 2023

Hedge funds, institutional investors and company insiders have been dumping shares of these risky pharma stocks.

3 Blue-Chip Dividend Stocks That Will Double in One Year

By Faisal Humayun, InvestorPlace Contributor Jun 27, 2023

These are the blue-chip dividend stocks to buy at deeply undervalued levels for 100% returns in the next 12 months

3 Stocks to Buy for Long-Term Dividends and Buybacks

By Marie Brodbeck, InvestorPlace Contributor Jun 26, 2023

These three are some of the best stocks for long-term dividends and buybacks thanks to their market-leading positions and strong finances.

Affordable Blue-Chips: 3 High-Potential Stocks With Low P/E Ratios

By Faisal Humayun, InvestorPlace Contributor Jun 26, 2023

These are the affordable blue-chip stocks to buy as they trade at a significant valuation gap.

Ready for a Rebound: 7 Blue-Chips Set to Regain Their Market Mojo

By Josh Enomoto, InvestorPlace Contributor Jun 20, 2023

Although blue-chip stocks to buy have a reputation for being slow and lumbering, these discounted ideas could swing higher.

3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever

By Chris Markoch, InvestorPlace Contributor Jun 20, 2023

Here are three long-term biotech stock investments that have the opportunity to turn risk -tolerant investors into millionaires.

Pfizer (PFE)

7 Dividend Stocks to Buy for Income and Upside

3 Massively Undervalued Blue-Chip Stocks for High Total Returns

3 Cheap Long-Term Stocks That Smart Investors Will Snap Up Now

Get Out Now! 7 Stocks to Dump After Sorry Q2 Earnings

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pfizer (PFE)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PFE Stock Predictions, Articles, and Pfizer News

Subscriber Sign in